New Frontier Data 8.23.23New Frontier Data 8.23.23New Frontier Data 8.23.23New Frontier Data 8.23.23
  • Solutions
    • Market Segments
      • Retailers & Dispensaries Business Data Solutions: Because you Wouldn't Leave Home Without a Map. Consumer Research, Customer Acquisition, and Competitive Conquesting
      • InvestorsBusiness Intelligence Data: It's what's De-Risking Cannabis. Market Intelligence, Opportunity Modeling, Due-Diligence Validation, and Risk Mitigation
      • BrandsBecause "cool" is not a brand strategy. Find the white space, Determine the market, and Model the revenue
      • Agencies & Consultants Unleash the Power of Informed Campaigns! +160M Probable cannabis consumers, +60M Cannabis Retail Visitors, Custom Audience Builder, and Cannabis Specific Marketing Reporting
      • Academia regulatory understanding, retail business intelligence and Medical Patient Research
    • Problems Solved
      • Customer AcquisitionTarget, engage, and retain customers.
      • Market Intelligence & ForecastingMaximize your profits, minimize risks.
      • Custom Research & ReportsKnow your market, grow your business.
      • Brand Visibility & ExposureBoost your business with our sponsorships.
      • Analytics for the Medical Cannabis SectorData for healthcare, policies, and patient care.
  • Products
    • Equio Make Informed Decisions with actionable Insights
    • NXTeck Transform your approach to customer acquisition
    • Custom Research
    • Analyst Reports
    • SponsorshipsBoost your business with our market.
    • CMedAccess extensive medical patient data
  • Resources
    • Blog
    • Events & Webinars
    • Podcast
    • Newsletter - Sign-Up Cannabit
  • Company
    • About Us
    • Board & Advisors
    • Our Partners
    • In The News
    • Press Releases & Media Kit
  • Equio Login
✕

The Fight for Weed

  • Home
  • Cannabis Insights
  • The Fight for Weed
New Frontier Data thumbnail
New Frontier Data To Power Benzinga’s Cannabis Investment Channel
May 16, 2018
New Frontier Data thumbnail
Adjusting Assumptions About California’s Too-Sunny Revenue Forecast
May 19, 2018
May 19, 2018
Categories
  • Cannabis Insights
  • Cannabit
Tags
img 115

By Bob Moss, Principal, National Director of Governmental Affairs for Cohn Reznick

For those of you that remember the 1971 top pop song, “I Feel the Earth Move” by Carole King, it was also in 1971 that President Nixon announced the War on Drugs, which classified marijuana as a Schedule 1 drug. Forty seven years later it seems the times are changing. In the White House, marijuana has been acknowledged from “I did not inhale” (1992 President Bill Clinton) to 2006 with President Obama –“I inhaled. Frequently…That was the point.”

In April, former House Speaker John Boehner, who once said he was opposed to decriminalizing marijuana laws, joined a board of directors for a cannabis company with an eye on rolling back federal regulations. These advocates state that their goal is to end federal marijuana enforcement and allow states to set their own marijuana policies without federal interference, not necessarily legalize it nationally.

This may change the way the industry and its marijuana campaign dollars are spent as well; with more money going to Republicans with the belief they support state’s rights more than the opposing party. But recent congressional action on the hill has been largely absent from garnering any Republican support. The “Marijuana Justice Act” (S1689) introduced in the U.S. Senate by Cory Booker last year, and the companion house bill H.R. 4815 introduced by Rep. Barbara Lee this year, have no Republican co-sponsors to date. This legislation amends the substance control act by removing marijuana from Schedule 1, and eliminates criminal penalties for an individual who imports, exports, manufactures, distributes, or possesses with intent to distribute marijuana.

Even with the changing viewpoint on marijuana legalization, there are some rather large opponents actively lobbying to keep marijuana out of reach. You may not be surprised by some of them, like the alcohol/beer lobby or big PhRMA (flashback 1990’s pharmaceutical companies reassured the medical industry that patients would not become addicted to opioid pain relievers), but private prison corporations are in the mix as well, providing a significant amount of campaign dollars to lawmakers.

But the evolution of marijuana continues. Former Speaker Boehner said his thinking has evolved. “I have concluded descheduling the drug is needed so that we can do research and allow VA to offer it as a treatment option in the fight against the opioid epidemic that is ravaging our communities,” he tweeted recently.

It may be slow, but the earth is moving.

Share
FacebookTwitterLinkedInPinterest
0

Related posts

4 1 2025 Cannabit Alcohol use by cannabis consumers
April 1, 2025

Cannabis Infused Beverages: The New Frontier of Intoxicating Libations?


Read more
Gender and purchasing
March 18, 2025

Gender differences and cannabis purchasing behavior


Read more
3 4 2025 Cannabit Consumer Density
March 4, 2025

Prohibition does little to impact supply and demand


Read more

Comments are closed.

The Fight for Weed

©2014-2025 New Frontier Data

HEADQUARTERS

5614 Connecticut Ave NW #331
Washington, DC 20015
info@nullnewfrontierdata.com
844-420-D8TA (3882)

MEDIA INQUIRIES

media@nullnewfrontierdata.com

FOLLOW US

social icon social icon social icon social icon social icon

COMPANY

FAQs
CONTACT US
CAREERS
PRESS RELEASES & MEDIA KIT
PRIVACY POLICY
TERMS OF USE